Home Pharmaceuticals CRISPR’s cardio catch-all drives a biotech’s broad potential

CRISPR’s cardio catch-all drives a biotech’s broad potential

by Newsroom


This audio is auto-generated. Please let us know if you have feedback.

Welcome to Biotech Spotlight, a series featuring companies creating breakthrough technologies and products. Today, we’re looking at Scribe Therapeutics, which is using CRISPR-based technology to target risk factors for the most common cause of death:…



Source link

You may also like

About Us

Health-Newswire.Net™ aggregates, publishes and distributed news about the Healthcare industry. In association with EmailWire, Health-Newswire.Net™ provides press release distribution services in the Healthcare sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Health Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC